Monday, July 23, 2018 4:23:03 PM
As for Regabatin and Rexista. The first is getting too old. Every month that goes by it is worth less and less in a partnership and now you can expect to get sued since the originator has an ER drug out. Also, it would still be years away from market and if they sue which they would add two more years to it and millions of $$$ to fight it. This isn't obvious? If they couldn't do a partnership a year or two ago what makes them think they can do it now?
The later if they finally go through and get approval and get it to market....maybe best case 16 more months to market? There are 10 ahead of them peddling their AD opioid already. So we are almost last or are last to market. AT one time we were at the front of the class. What a shame.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM